DocGo (DCGO) Competitors $5.54 -0.02 (-0.36%) Closing price 02/14/2025 04:00 PM EasternExtended Trading$5.43 -0.11 (-1.97%) As of 02/14/2025 07:29 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends DCGO vs. PACS, ADUS, ARDT, PGNY, WGS, NHC, VRDN, AGL, FTRE, and CDNAShould you be buying DocGo stock or one of its competitors? The main competitors of DocGo include PACS Group (PACS), Addus HomeCare (ADUS), Ardent Health Partners (ARDT), Progyny (PGNY), GeneDx (WGS), National HealthCare (NHC), Viridian Therapeutics (VRDN), agilon health (AGL), Fortrea (FTRE), and CareDx (CDNA). These companies are all part of the "healthcare" industry. DocGo vs. PACS Group Addus HomeCare Ardent Health Partners Progyny GeneDx National HealthCare Viridian Therapeutics agilon health Fortrea CareDx DocGo (NASDAQ:DCGO) and PACS Group (NYSE:PACS) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, institutional ownership, risk, valuation, earnings, profitability, community ranking, media sentiment and analyst recommendations. Is DCGO or PACS more profitable? DocGo has a net margin of 4.35% compared to PACS Group's net margin of 0.00%. DocGo's return on equity of 8.90% beat PACS Group's return on equity.Company Net Margins Return on Equity Return on Assets DocGo4.35% 8.90% 5.72% PACS Group N/A N/A N/A Do insiders & institutionals believe in DCGO or PACS? 56.4% of DocGo shares are held by institutional investors. 2.7% of DocGo shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Do analysts recommend DCGO or PACS? DocGo presently has a consensus price target of $6.10, indicating a potential upside of 10.11%. PACS Group has a consensus price target of $34.00, indicating a potential upside of 153.52%. Given PACS Group's higher probable upside, analysts plainly believe PACS Group is more favorable than DocGo.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score DocGo 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 3.00PACS Group 0 Sell rating(s) 1 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.88 Which has stronger earnings & valuation, DCGO or PACS? PACS Group has higher revenue and earnings than DocGo. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDocGo$694.97M0.81$6.86M$0.2819.79PACS Group$3.11B0.66$112.87MN/AN/A Does the MarketBeat Community prefer DCGO or PACS? DocGo received 22 more outperform votes than PACS Group when rated by MarketBeat users. However, 95.83% of users gave PACS Group an outperform vote while only 75.00% of users gave DocGo an outperform vote. CompanyUnderperformOutperformDocGoOutperform Votes4575.00% Underperform Votes1525.00% PACS GroupOutperform Votes2395.83% Underperform Votes14.17% Does the media prefer DCGO or PACS? In the previous week, PACS Group had 3 more articles in the media than DocGo. MarketBeat recorded 4 mentions for PACS Group and 1 mentions for DocGo. PACS Group's average media sentiment score of 0.24 beat DocGo's score of 0.22 indicating that PACS Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment DocGo 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral PACS Group 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryDocGo beats PACS Group on 8 of the 15 factors compared between the two stocks. Get DocGo News Delivered to You Automatically Sign up to receive the latest news and ratings for DCGO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DCGO vs. The Competition Export to ExcelMetricDocGoHealth services IndustryMedical SectorNASDAQ ExchangeMarket Cap$565.36M$966.48M$5.76B$9.22BDividend YieldN/A2.01%5.27%4.00%P/E Ratio19.7936.0726.2019.44Price / Sales0.814.04456.5777.34Price / Cash23.0625.3046.0638.90Price / Book1.892.967.355.05Net Income$6.86M-$3.49M$3.19B$222.81M7 Day Performance1.84%13.27%1.69%1.29%1 Month Performance32.85%11.88%4.13%1.52%1 Year Performance50.14%125.77%22.24%16.53% DocGo Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DCGODocGo1.3161 of 5 stars$5.54-0.4%$6.10+10.1%+50.1%$565.36M$694.97M19.794,164PACSPACS Group4.0963 of 5 stars$14.18+0.6%$34.00+139.7%N/A$2.16B$3.11B0.0032,433ADUSAddus HomeCare4.7354 of 5 stars$116.46+0.3%$134.22+15.3%+20.1%$2.11B$1.13B26.6534,846Upcoming EarningsShort Interest ↓ARDTArdent Health PartnersN/A$14.74-1.7%$21.55+46.2%N/A$2.10B$5.71B0.0024,200PGNYProgyny2.3416 of 5 stars$22.35+2.0%$25.50+14.1%-45.2%$1.90B$1.09B38.54310WGSGeneDx1.3098 of 5 stars$68.15+14.5%$70.67+3.7%+1,411.9%$1.87B$202.57M-21.911,200NHCNational HealthCareN/A$100.71+1.0%N/AN/A$1.55B$1.14B12.6213,123Dividend AnnouncementVRDNViridian Therapeutics2.3806 of 5 stars$17.98+1.2%$35.70+98.6%-11.8%$1.42B$310,000.00-4.1750AGLagilon health2.2945 of 5 stars$3.29-1.4%$4.03+22.6%-51.8%$1.35B$4.32B-3.491,117Short Interest ↓FTREFortrea2.4075 of 5 stars$15.07+1.1%$23.30+54.6%-58.0%$1.35B$3.11B-4.4118,000CDNACareDx3.23 of 5 stars$24.91+11.2%$28.33+13.7%+201.4%$1.34B$312.78M-9.23740Positive NewsHigh Trading Volume Related Companies and Tools Related Companies PACS Alternatives ADUS Alternatives ARDT Alternatives PGNY Alternatives WGS Alternatives NHC Alternatives VRDN Alternatives AGL Alternatives FTRE Alternatives CDNA Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:DCGO) was last updated on 2/17/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredTop Picks for Trump’s Pro-Crypto America10,000% Crypto Opportunities in 2025 27 of the brightest minds in crypto share exclusive intel… Crypto 101 Media | SponsoredHe called the top and bottom of Bitcoin nearly to the day … Here’s what he says is next.With Donald Trump’s return to the oval office, the war on crypto is over. The digital currency is not only ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DocGo Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share DocGo With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.